December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Carter's, Inc. Common Stock (NY:CRI)

35.23 -2.54 (-6.72%)
Streaming Delayed Price Updated: 3:08 PM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Carter's, Inc. Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Carter’s, Inc. Releases 2021 Corporate Social Responsibility Report
From Carter’s, Inc.
Via Business Wire
News headline image
Carter's Q2 Earnings Miss Estimates ↗
 
Via Benzinga
News headline image
Carter's: Q2 Earnings Insights ↗
  Carter's (NYSE:CRI) reported its Q2 earnings results on Friday, July 29, 2022 at 06:10 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Carter’s, Inc. Reports Second Quarter Fiscal 2022 Results
From Carter’s, Inc.
Via Business Wire
News headline image
Carter’s, Inc. to Report Second Quarter Fiscal 2022 Results on Friday, July 29, 2022
From Carter’s, Inc.
Via Business Wire
News headline image
Expert Ratings for Carter's ↗
Within the last quarter, Carter's (NYSE:CRI) has observed the following analyst ratings: 
Via Benzinga
News headline image
Carter's Stock Slides On Street-Missing Q2 Outlook ↗
 
Via Benzinga
News headline image
Carter's: Q1 Earnings Insights ↗
Carter's (NYSE:CRI) reported its Q1 earnings results on Friday, April 29, 2022 at 06:23 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Earnings Scheduled For July 29, 2022 ↗
Companies Reporting Before The Bell • Capital Product Partners (NASDAQ:CPLP) is expected to report quarterly earnings at $1.13 per share on revenue of $72.73 million. 
Via Benzinga
News headline image
Why Walmart is Trading Higher By More Than 9%: Here Are 25 Stocks Moving Premarket ↗
Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) rose 64.4% to $1.43 in pre-market trading. Ayala Pharmaceuticals filed request for withdrawal of registration statement on form S-1. 
Via Benzinga
News headline image
Where Carter's Stands With Analysts ↗
Analysts have provided the following ratings for Carter's (NYSE:CRI) within the last quarter: 
Via Benzinga
News headline image
6 Undervalued Dividend Stocks to Buy Before July 2022 ↗
These undervalued dividend stocks have good yield, low price-to-earnings, and enough positive earnings to cover their dividend payments. 
Via InvestorPlace
News headline image
6 Undervalued Dividend Stocks to Buy in July 2022 ↗
These undervalued dividend stocks have good yield, low price-to-earnings, and enough positive earnings to cover their dividend payments. 
Via InvestorPlace
News headline image
6 Oversold Dividend Stocks With High Yields to Buy Now ↗
These 6 oversold dividend stocks with high yields are worth buying as their yields will help the stock return to metrics of intrinsic value. 
Via InvestorPlace
News headline image
6 Beaten-Down Stocks With Promising Potential ↗
These six beaten-down stocks with promising potential can make a patient value investor money, especially if there is a good dividend yield. 
Via InvestorPlace
News headline image
OshKosh B’gosh Encourages a New Kind of Togetherness this Father’s Day with Launch of ‘Take Your Dad to the Metaverse Day’
From Carter’s, Inc.
Via Business Wire
News headline image
The Shakeout In Financials May Have Set The Sector Up For Success ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
News headline image
Thursday Is Your Last Chance To Buy Carter's Before The Dividend Payout ↗
Thursday marks the last chance for investors to receive the next dividend payout from Carter's (NYSE:CRI). 
Via Benzinga
News headline image
Carter’s, Inc. Announces Quarterly Dividend
From Carter’s, Inc.
Via Business Wire
News headline image
Carter’s Appoints Hilary Duff as Chief Mom Officer
From Carter’s, Inc.
Via Business Wire
News headline image
Best Stocks To Buy Now May 6, 2022
Today the S&P500 opened the market at $4,161; the Dow Jones today trades at $33,159, and the Nasdaq reached $156.9. The latter 
Via Best Stocks
Topics Stocks
News headline image
Carter's Earnings Perspective: Return On Invested Capital ↗
According to Benzinga Pro, during Q1, Carter's (NYSE:CRI) earned $67.93 million, a 29.95% increase from the preceding quarter. Carter's's sales decreased to $781.28 million, a 26.43% change since Q4. 
Via Benzinga
News headline image
Carter’s, Inc. Reports First Quarter Fiscal 2022 Results
From Carter’s, Inc.
Via Business Wire
News headline image
Earnings Scheduled For April 29, 2022 ↗
Companies Reporting Before The Bell • Weyerhaeuser (NYSE:WY) is projected to report quarterly earnings at $1.19 per share on revenue of $2.93 billion. 
Via Benzinga
News headline image
Carter's's Earnings Outlook ↗
Carter's (NYSE:CRI) is set to give its latest quarterly earnings report on Friday, 2022-04-29. Here's what investors need to know before the announcement. Analysts estimate that Carter's will report an... 
Via Benzinga
News headline image
Why BofA Downgrades Carter's Ahead Of Q1 Print ↗
Carter's, Inc. (NYSE: CRI) faces a risk to margins as the promotional environment normalizes, according to Bofa Securities. 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Wednesday ↗
RBC Capital lowered General Motors Company (NYSE: GM) price target from $70 to $58. GM shares rose 1.9% to $38.75 in pre-market trading. 
Via Benzinga
News headline image
Carter’s, Inc. to Report First Quarter Fiscal 2022 Results on Friday, April 29, 2022
From Carter’s, Inc.
Via Business Wire
News headline image
Carter’s, Inc. Introduces ‘Raise the Future™,’ a Commitment to Inspire Generations Raising the Future
From Carter’s, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2022 ↗
Upgrades According to Brookline Capital, the prior rating for Intellia Therapeutics Inc (NASDAQ:NTLA) was changed from Hold to Buy. In the fourth quarter, Intellia Therapeutics... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.